Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.06
Elon Musk Confirms Cybertruck Production Wind-Down at Texas Factory as Tesla Makes Room for Cybercab
Benzinga
2026.11.06
Trump Calls 2022 Law Blocking Russian Diesel Imports 'Pretty Bad Law' as Ukraine Strikes Refineries, Tankers Change Course
Benzinga
2026.11.06
VEON Q3 EPS $2.67 Beats $1.57 Estimate, Sales $1.307B Miss $1.308B Estimate
Benzinga
2026.11.06
Hong Kong Exchanges Q3 EPS $3.84 Down From $3.88 YoY, Sales $7.867B Up From $7.775B YoY
Benzinga
2026.11.06
'Major Investors Are Skeptical Anthropic IPO Can Achieve $1.5 Trillion Valuation' - WSJ
Benzinga
2026.11.06
'China's Top Flash Memory Chipmaker Targets More Homegrown Tools for New Factory, Sources Say' - Reuters Exclusive
Benzinga
2026.11.06
Under Armour Likely To Report Lower Q2 Revenue; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga
2026.11.06
Humana Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga
2026.11.06
Jim Cramer Raises Red Flags Over CoreWeave, IREN and Nebius Data Center Expansion: 'These Are What I Am Concerned About'
Benzinga
2026.11.06
Intl Cons Airlines Group Q3 Adj. EPS $0.62 Misses $0.67 Estimate, Sales $11.214B Beat $10.890B Estimate
Benzinga
2026.11.06
Top Wall Street Forecasters Revamp Vistra Expectations Ahead Of Q3 Earnings
Benzinga
2026.11.06
Intl Cons Airlines Group Q3 Adj. EPS €0.27 Down From €0.29 YoY, Sales €9.744B
Benzinga
2026.11.06
OpenAI's New GPT-6 Cyber AI Can Find and Exploit Software Flaws — It Already Uncovered 588 Unknown Linux Vulnerabilities and 81 Firefox Bugs
Benzinga
2026.11.06
Nasdaq Tumbles 5.5% as AI Stocks Crater: Investor Sentiment Weakens, Fear & Greed Index Moves to ‘Extreme Fear’ Zone
Benzinga
2026.11.06
Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga
2026.11.06
KDDI Q2 EPS ¥45.47 Down From ¥52.13 YoY, Sales ¥156.550B Up From ¥150.027B YoY
Benzinga
2026.11.06
Airbnb, Charter Communications and 3 Stocks to Watch Heading Into Friday
Benzinga
2026.11.06
Core Scientific to Exit Bitcoin Mining by Year-End and Become a Pure-Play AI Data Center Provider
Benzinga
2026.11.06
Tesla To Wind Down Cybertruck Production At Gigafactory Texas Around Mid-Next Year To Make Room For Increased Cybercab Production
Benzinga
2026.11.06
RedCloud (RCT) Stock Jumps Over 38% After Hours: Here’s What You Need to Know
Benzinga
2026.11.06
'Campaign Promises Look a Lot Different:' Analyst Mocks Anti-Data Center Politicians as Meta President Reveals Governor's Request
Benzinga
2026.11.06
Crypto’s Toughest Critic, Set to Chair Senate Banking: Can She Move Prices?
BeInCrypto
2026.11.06
Trump Ally Santiago Peña's Resignation Rejected as Paraguay Impeaches Him Over $800 Million Ueno Bank Crisis
Benzinga
2026.11.06
Mediobanca Q3 Adj. EPS €0.49 Up From €0.35 YoY, Sales €977.400M Up From €849.000M YoY
Benzinga
2026.11.06
Robotaxis Aren't Killing Lyft's Business: CEO Says Company Is Growing in AV Markets, Details Waymo Partnership
Benzinga
2026.11.06
Source Energy Services Q3 EPS $(0.29) Misses $(0.08) Estimate, Sales $188.027M Beat $169.700M Estimate
Benzinga
2026.11.06
Pharming Receives U.K. Approval For Joenja In Children Aged 4 To 11 With APDS, Supported By Pediatric Clinical Program Data; Marks Step In Expansion Across Age Groups And Markets
Benzinga
2026.11.06
Molecular Partners Says MP0632 Preclinical Data At SITC 2026 Show No Detectable Impact On Healthy Mesothelial Or Epithelial Cells, Supporting IND-Enabling Studies In MSLN And EpCAM Solid Tumors
Benzinga
2026.11.06
Kyivstar Group Q3 EPS $0.36 Beats $0.34 Estimate, Sales $349.000M Beat $334.380M Estimate
Benzinga
2026.11.06
Reported Earlier, Perspective Therapeutics Says Bamzireotide Delivers 37% ORR In All 68 Treated NET Patients, 91% Disease Control, Median Follow-Up Up To 128 Weeks; Grade 3 TEAEs In 29%, No Grade 4 Or 5 Events
Benzinga
1
...
201
202
203
204
205
206
...
712
>